These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 10578521

  • 1. Exploring the role of the beta-adrenergic receptor kinase in cardiac disease using gene-targeted mice.
    Koch WJ, Rockman HA.
    Trends Cardiovasc Med; 1999; 9(3-4):77-81. PubMed ID: 10578521
    [Abstract] [Full Text] [Related]

  • 2. Myocardial G protein-coupled receptor kinases: implications for heart failure therapy.
    Iaccarino G, Lefkowitz RJ, Koch WJ.
    Proc Assoc Am Physicians; 1999; 111(5):399-405. PubMed ID: 10519160
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beta-adrenergic axis and heart disease.
    Naga Prasad SV, Nienaber J, Rockman HA.
    Trends Genet; 2001 Oct; 17(10):S44-9. PubMed ID: 11585676
    [Abstract] [Full Text] [Related]

  • 5. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
    Koch WJ.
    Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The beta-adrenergic receptor kinase in heart failure.
    Petrofski JA, Koch WJ.
    J Mol Cell Cardiol; 2003 Oct; 35(10):1167-74. PubMed ID: 14519424
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recent advances in cardiac beta(2)-adrenergic signal transduction.
    Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG.
    Circ Res; 1999 Nov 26; 85(11):1092-100. PubMed ID: 10571541
    [Abstract] [Full Text] [Related]

  • 10. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
    Perrino C, Naga Prasad SV, Patel M, Wolf MJ, Rockman HA.
    J Am Coll Cardiol; 2005 Jun 07; 45(11):1862-70. PubMed ID: 15936620
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury.
    Cross HR, Steenbergen C, Lefkowitz RJ, Koch WJ, Murphy E.
    Circ Res; 1999 Nov 26; 85(11):1077-84. PubMed ID: 10571539
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.
    Hata JA, Williams ML, Koch WJ.
    J Mol Cell Cardiol; 2004 Jul 26; 37(1):11-21. PubMed ID: 15242731
    [Abstract] [Full Text] [Related]

  • 14. What is the role of beta-adrenergic signaling in heart failure?
    Lohse MJ, Engelhardt S, Eschenhagen T.
    Circ Res; 2003 Nov 14; 93(10):896-906. PubMed ID: 14615493
    [Abstract] [Full Text] [Related]

  • 15. Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors.
    Iaccarino G, Keys JR, Rapacciuolo A, Shotwell KF, Lefkowitz RJ, Rockman HA, Koch WJ.
    J Am Coll Cardiol; 2001 Aug 14; 38(2):534-40. PubMed ID: 11499749
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.
    Anderson KM, Eckhart AD, Willette RN, Koch WJ.
    Hypertension; 1999 Jan 14; 33(1 Pt 2):402-7. PubMed ID: 9931137
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.